Pyoderma gangrenosum triggered by insect bite: two case reports
DOI:
https://doi.org/10.66344/jpad.18.3.2008.593Keywords:
Pyoderma gangrenosum, insect bite, corticosteriods.Abstract
Pyoderma gangrenosum is rare, probably autoimmune vascutitis and non-infective ulceration of skin. Two case reports are presented here, with interesting similarities and probable cause.ÂReferences
Barham KL, Jorizzo JL, Grattan B, Cox NH. Vasculitis and neutrophilic vascular reactions. n: Burns T, Breathnach SM, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 7th edn. London: Blackwell Science; 2004. p. 49.1-49.46.
Perry HO, Winkelmann RK. Bullous Pyoderma gangrenosum and leukemia. Arch Dermatol 1972; 106: 901-5
Andersen BL. Pyoderma gangrenosum associated with transient acantholytic dermatosis and para proteinaemia. Acta Derm Venereol (Stockh) 1981; 61: 77-9.
Su WD, Schroeter AL, Perry HO et al. Histopathologic and immunologic study of pyoderma gangrenosum. J Cutan Pathol 1986; 13: 323-30.
Check IJ, Ellington EP, Moreland A et al. T helper – suppressor cell imbalance in pyoderma gangrenosum. Am J Clin Pathol 1983; 80: 396-9.
Jones RR, Black AK, Metal D. Defective monocyte function in pyoderma gangrenosum. Clin Exp Immunol 1983; 52: 685-92.
Chevrant Breton J, Logeais B, Piboin M. Pyoderma gangrenosum. Pyodermite phagedenique Ann Dermatol Venereol 1989; 116: 577-89.
Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma gangrenosum. Arch Dermatol Syphilot 1930; 22: 655-80.
Stathers GM, Abbot LG, McGuiness AE. Pyoderma gangrenosum in association with regional enteritis. Arch Dermatol 1967; 95: 375-80.
Philpott JA, Goltz RW, Park RK. Pyoderma gangrenosum, rheumatoid arthritis and diabetes mellitus. Arch Dermatol 1966; 94: 732-8.
Byrne JP, Hewitt M, Summerly R. Pyoderma gangrenosum associated with active chronic hepatitis. Arch Dermatol 1976; 112: 1297-9.
Su WP, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunologic study of Pyoderma gangrenosum. J Cutan Pathol 1986; 13: 323-3.
Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloprotiferative disorders. Atypical forms of pyoderma gangrenosum and Sweet’s syndrome associate with myeloproliferative disorders. J Am Acad Dermatol 1983: 9; 751-8.
Auletta MJ, Headington JT, Purpura fulminans. Arch Dermatol 1988, 124: 1387-91.
Poller C. Disseminated intravascular coagulation Prescribers J 1989; 29: 234-8.
Baglin T. Disseminated intravascular coagulation. Diagnosis and treatment. Br Med J 1996; 312: 683-7.
Drouhet E, Destombes P, Carrizales D. Cryptoccocose cutanee, confrontations histologiques et mycologiques. Bull Soc Dermatol Syphiligr 1970; 77: 735-41.
Rook A, Woods B. Cutaneous cryptococcosis Br J Dermatol 1962; 74: 43-9.
Darke SG, King AM, Slack WK. Gas gangrene and related infections. A report of 88 cases. Br J Surg 1977; 64: 104-12.
Weinstain L, Barza M. Gas gangrene. N Engl J Med 1973; 289: 1129-36.
Curley RK. Macfarlane AW, Vickers CFH. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985, 113: 601-4.
Rasmussen I. Pyoderma gangrenosum treated with clofazimine. Acta Derm Venereol (Stockh) 1983; 63: 552-3.
Berth-Jones J. Tan SV. Graham Brown RAC et al. Successful use of minocycline in pyoderma gangrenosum in a report of seven cases. J Dermatol Treat 1989; 1: 23-5.
Gupta AK, Sheer NH, Sander DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995; 32: 140-2.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.